1. Home
  2. CBL vs IMTX Comparison

CBL vs IMTX Comparison

Compare CBL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBL & Associates Properties Inc.

CBL

CBL & Associates Properties Inc.

N/A

Current Price

$49.57

Market Cap

1.5B

Sector

Real Estate

ML Signal

N/A

Logo Immatics N.V.

IMTX

Immatics N.V.

N/A

Current Price

$5.78

Market Cap

992.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBL
IMTX
Founded
1978
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
992.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CBL
IMTX
Price
$49.57
$5.78
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $16.03
AVG Volume (30 Days)
184.1K
★ 987.4K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
★ 5.47%
N/A
EPS Growth
★ 132.09
N/A
EPS
★ 3.31
N/A
Revenue
★ $578,373,000.00
N/A
Revenue This Year
$1.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.76
★ N/A
Revenue Growth
★ 12.18
N/A
52 Week Low
$32.52
$5.83
52 Week High
$60.40
$12.41

Technical Indicators

Market Signals
Indicator
CBL
IMTX
Relative Strength Index (RSI) 44.63 29.49
Support Level $46.62 N/A
Resistance Level $50.01 $11.82
Average True Range (ATR) 2.09 0.45
MACD -0.06 -0.04
Stochastic Oscillator 34.17 2.50

Price Performance

Historical Comparison
CBL
IMTX

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: